Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.0%

11 terminated/withdrawn out of 100 trials

Success Rate

87.6%

+1.1% vs industry average

Late-Stage Pipeline

48%

48 trials in Phase 3/4

Results Transparency

17%

13 of 78 completed trials have results

Key Signals

3 recruiting13 with results10 terminated

Enrollment Performance

Analytics

Phase 4
25(30.5%)
Phase 3
23(28.0%)
N/A
16(19.5%)
Phase 2
10(12.2%)
Phase 1
8(9.8%)
82Total
Phase 4(25)
Phase 3(23)
N/A(16)
Phase 2(10)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (100)

Showing 20 of 100 trials
NCT05055297Not ApplicableRecruiting

SELUTION4BTK Trial

Role: collaborator

NCT07246902Recruiting

Mobilization and Outcomes After Venous Closure

Role: lead

NCT07204678Completed

PMCF Study of Precise Pro Rx for Carotid Artery Disease

Role: lead

NCT07338890Not Yet Recruiting

Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

Role: lead

NCT05132361Not ApplicableActive Not Recruiting

SELUTION4SFA Trial

Role: collaborator

NCT00292305Phase 4Completed

Nordic Bifurcation Stent Technique Study (BIF II)

Role: collaborator

NCT04280029Not ApplicableActive Not Recruiting

SELUTION SLR™ 014 In-stent Restenosis

Role: collaborator

NCT05946629Not ApplicableRecruiting

SELUTION 4 De Novo Small Vessel IDE Trial

Role: collaborator

NCT07122518Not Yet Recruiting

Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis

Role: lead

NCT05399680Not ApplicableCompleted

Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

Role: lead

NCT05554471Not ApplicableCompleted

Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression

Role: lead

NCT01664078Not ApplicableCompleted

A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)

Role: lead

NCT02477111Completed

European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms

Role: lead

NCT05543096Completed

PMCF Study for Cardiology Access Procedures

Role: lead

NCT05312580Completed

PMCF Study for Peripheral Arteries Above the Knee (ATK)

Role: lead

NCT05444660Completed

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Role: lead

NCT02060630Not ApplicableCompleted

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia

Role: collaborator

NCT01106391Not ApplicableCompleted

A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)

Role: lead

NCT00422565Phase 4Terminated

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients

Role: collaborator

NCT03923387Not ApplicableCompleted

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device

Role: lead